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Abstract
Background: While the number of detected COVID-19 infections are widely available, an understanding of the
extent of undetected cases is urgently needed for an effective tackling of the pandemic. The aim of this work is
to estimate the true number of COVID-19 (detected and undetected) infections in several European countries.
The question being asked is: How many cases have actually occurred?
Methods: We propose an upper bound estimator under cumulative data distributions, in an open population,
based on a day-wise estimator that allows for heterogeneity. The estimator is data-driven and can be easily
computed from the distributions of daily cases and deaths. Uncertainty surrounding the estimates is obtained
using bootstrap methods.
Results: We focus on the ratio of the total estimated cases to the observed cases at April 17th. Differences arise
at the country level, and we get estimates ranging from the 3.93 times of Norway to the 7.94 times of France.
Accurate estimates are obtained, as bootstrap-based intervals are rather narrow.
Conclusions: Many parametric or semi-parametric models have been developed to estimate the population
size fromaggregated counts leading to an approximation of themissedpopulation and/or to the estimate of the
threshold under which the number of missed people cannot fall (i.e. a lower bound). Here, we provide a
methodological contribution introducing an upper bound estimator and provide reliable estimates on the dark
number, i.e. howmany undetected cases are going around for several European countries, where the epidemic
spreads differently.
Keywords: capture–recapture methods; COVID-19; geometric distribution; Chao’s lower bound.
Introduction
The severe acute respiratory syndrome coronavirus 2 (COVID-19) has become a pandemic within few weeks.
The number of detected cases increased day-by-day, at an exponential rate at the beginning, andnow follows a
logistic distribution (Petropoulos andMakridakis 2020; Sebastiani, Massa, andRiboli 2020). Cases of COVID-19
might have been vastly underreported in official statistics. It is widely acknowledged that the majority of the
cases are asymptomatic and, thus, not observed or recorded (Böhning et al. 2020; Tuite et al. 2020; Yue,
Clapham, and Cook 2020). In other words, the available data just tell us a part of the story: individuals may be
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already infected but are not aware of it, maybe because of the absence of symptoms, or cases may be under
symptomatic suspicion but the disease has not been diagnosed yet (due to the delay in getting swab results).
The total number of cases is thus unknown, and general comments on the spread of the epidemic are thus
partial as based on a (relatively small) fraction of the total cases. Some studies have used simulation-based
approaches to infer reasonable estimates of total number of cases, but often these estimates are surrounded by
poor uncertainty measures, leading to too wide confidence intervals (Flaxman et al. 2020). Many studies have
also claimed that the number of undiagnosed cases is much higher than the official number (Li et al. 2020;
Pollan et al. 2020; Phipps, Grafton, andKompas 2020;Mukhopadhyay andChakraborty 2020; Rothe et al. 2020;
Yu et al. 2020). Here, we are proposing a simple and effective method to obtain reasonable point and interval
estimates of the total number of COVID-19 infections in several European countries. In detail, we introduce a
novel estimator based on a capture recapture (CR) approach. The capture–recapture method should be
considered as the gold standard for counting when it is impossible to identify each case and large undercounts
will occur (Lange and LaPorte 2003). CR methods were originally developed in the ecological setting with the
aim of estimating the unknown size of a (possibly elusive) population and then they started to be applied also
to epidemiological and health sectors (see Böhning, van der Heijden, and Bunge 2019; McRea and Morgan
2015). Many CR estimators have been proposed in the literature (see e.g. Tilling 2001;Wesson,Mirzazadeh, and
McFarland 2018;Wesson et al. 2019), and some of themcan be used to identify lower bounds (Chao andColwell
2017) of the population size. In the analysis of COVID-19 infections, official data are available at the aggregated
level, whereas individual data are not available to the general or the academic public. Hence, it is not possible
to get the exact distribution of the number of infected individuals observed exactly one day, exactly two days
and so on until m days. The population is open, subjected to deaths, and this may further complicate the
analysis (McDonald and Amstrup 2001). A lower bound of the total number of infected cases is computed by
Böhning et al. (2020) modifying the Chao estimator (Niwitpong et al. 2013) to address issues related to the data
at hand. This is a relevant result as it provides reasonable information to the policy makers about the unde-
tected cases and the magnitude this phenomenon may have at least, so that national health systems may be
aware of theminimumnumber of cases thatmay demand health care services. At this stage of the spread of the
epidemic, governments are willing to relax restrictive measures and several researches address issues related
to the epidemic (Gregori et al. 2020; Khalatbari-Soltani et al. 2020; Lai 2020). To calibrate the new in-
terventions, an estimate of the lower bound of the number of infections may not be enough, as COVID-19 has
already shown to spread around the population very quickly (Li et al. 2020; Zhao et al. 2020; Zhou et al. 2020).
This contribution aims at providing an approximated upper bound for the total number of COVID-19 cases, to
better appreciate the dimension of the epidemic, under theworse scenario. Such an estimate is obtained from a
non-parametric CR model, providing an upper bound estimate of the total number of infections regardless of
the true data generating process.
This contribution is organized as follows. In “Methods” section, we introduce the basic notation and how
we are going to work with the data at hand. A brief summary of the modified Chao lower bound is also
discussed. These notions are then used to compute the upper bound, details of which are provided in “Data
analysis” section, along with the computation of the uncertainty surrounding the estimates. In “Conclusions”
section, we show the empirical application of the proposal on data from several European countries. A
discussion showing other interesting insights concludes.
Methods
Preliminaries
Let us denote with N(t) the cumulative count of infections at day t where t=t0,…, tm. Hence ΔN(t)=N(t) − N(t−1) are the number of
new infections at day twhere t=t0 + 1,…, tm. Also, letD(t) denote the cumulative count of deaths at day twhere t=t0,…, tm. t0 defines
the beginning of the observational period and tm defines the end. We assume the trivial assumption tm>t0, so that the observational
window is not empty. Again, we denote with ΔD(t)=D(t)−D(t−1) the count of new deaths at day t where t=t0 + 1, …, tm.
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The question arises how this can be linked to a capture–recapture approach. Let Xi denote the number of identifications for
each infected individual i typically provided by the days the individual will surely remain infected. Let denote τx the probability of
identifying an individual x timeswhere x=0,…A lower bound estimator of the unobserved frequency f0, say f̂ 0, can be estimated by
using the observed frequency of those identified exactly once, f1, and of those identified twice, f2 (Chao and Colwell 2017; Niwitpong
et al. 2013):
f̂ 0  f 21 /f2  . (1)
It is thus crucial to relate f1 and f2 with thedata at hand. Indetail, at eachday t, f1(t) represents the infectedpeople identified just once,
i.e. the new infections, whose number is given by ΔN(t). Similarly, f2(t) represents the infected people detected at time (t − 1) and still
infected at time t. This can be computed as ΔN(t − 1) − ΔD(t). Hence the estimate for the number of hidden infections at day t is
f̂ 0(t)  [ΔN(t)]
2
ΔN(t − 1) − ΔD(t) . (2)
By applying the estimator (1) day-wise we get the modified Chao lower bound estimator (see Böhning et al. 2020):




ΔN(t − 1) − ΔD(t). (3)
In practice, however, the bias-corrected form of (3) suggested by Chao (1989) is used:




1 + ΔN(t − 1) − ΔD(t). (4)
We define the understanding that ΔN(t − 1) − ΔD(t) is set to 0 if it becomes negative, in other words we use
max{0,ΔN(t − 1) − ΔD(t)}. The final estimate of lower bound (LB) of the total number of infection is then given as what has been
observed at the end of the observational window tm and the estimate of the hidden numbers:
NLB  N(tm) + f̂ 0 (5)
The upper bound estimator
The lower bound is helpful as an indication of the minimumnumber of people having had COVID-19 and answers to a fundamental
open question: “Howmany undetected cases are at least going around?”. Nevertheless, this informationmay be treated as a starting
point whenever interventions and tools to dampen the spread of the epidemic are rolled out. The proposed upper bound estimator
extends the researchon theundetected cases andhelpspolicymakers to evaluate the COVID-19 epidemic situation locally and at the
current phase of its development. An estimate of the worse possible scenario is provided.
Following a similar strategy as in “Preliminaries” section, this is achievedbyfirstly estimatingdaily-specific upper-bounds and
then summing up all the estimates to get the final point-estimate of the maximum number of undetected cases. This daily-wise
based upper bound approach provides an approximation of the data generation process.
Let us introduce the cumulative distribution function
πij  Pr(Xi ≤ j)  Pr(Xi  0) + Pr(0 < Xi ≤ j)  πi0 + (1 − πi0)pij  , (6)
where homogeneity in the probability of being infected at a certain date t is assumed, i.e. πij=πj, with pij=pj being the cumulative
zero-truncated probability distribution. Equation (6) represents the probability that an individual is infected for atmost jdays, and it
is function of π0 and pj; but π0 is not observed. The quantities pj(j=1, 2, 3) in Eq. (6) at each time t may be approximated as
p1(t)  f1(t)/n∗obs(t) ,
p2(t)  (f1(t) + f2(t))/n∗obs(t),
p3(t)  (f1(t) + f2(t) + f3(t))/n∗obs(t)
where f1(t) and f2(t) have been introduced in the previous section and
f3(t)  ΔN(t − 2) − ΔD(t − 1) − ΔD(t).
and n∗obs(t) is the number of current infected individuals observed at each time. We think that it is reasonable, for each day t, to
consider the number of individuals affected by COVID-19 for the day t, for day t and the day before, and, for day t and the two days
before, as m=3 is the minimum number of consecutive days of new infections necessary for the upper bound estimator to be
computed. Furthermore, considering more than three days for an individual to be observed as affected by COVID-19 would lead to
the risk of not observing the number of people affected by COVID-19 for exactly four, five and so on times because of the higher risk
of overlapping cases.
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Since π0 is unknown, to compute the probabilities in (6), we substitute it with
π̂0(t)  f̂ 0(t)
f1(t) + f2(t) + f̂ 0(t)
 .
where f̂ 0(t) is the lower bound probability of undetected cases derived from the Chao estimator in its bias corrected form, computed
at each time t (see Eq. (2)). This also explainswhy a lot of detailwas devoted to the lower boundestimator in the previous section as it
is verymuch needed here. In other words, based on the Chao lower bound estimator of the undetected cases, we derive the complete
count distribution and calculate the upper bound for the population size on such a complete distribution. Now, it follows that Eq. (6)
takes the form
π̂j(t)  π̂0(t) + (1 − π̂0(t))pj(t)
when theoretical probabilities are replaced by their now available estimates. In order to provide an upper bound estimator we use
the main results of Alfó, Böhning, and Rocchetti (2020):
πj ≤ pj⎡⎢⎢⎣1 − (1 − pj)⎛⎜⎝ pj+1 − pj
pj+1 − pj π̂jπ̂j+1
⎞⎟⎠⎤⎥⎥⎦−1  .





) + pm−1 − pm−2
 π̂UB0  ;
that makes clear why at least m=3 days should be considered. The right-hand side π̂UB0 of the above inequality provides an upper
bound estimate of the population size based on the Horvitz–Thompson estimator:
f̂
UB








π̂2(t)) + p2(t) − p1(t)
 .
To get an estimate for themissed COVID-19 infections f̂ 0(t) at each time twe compute the Horvitz–Thompson (HT) estimator at










Hence, the approximated upper bound of the total number of infected people, N̂UB, in the time window from t0 to tm is then
given by
N̂UB  f̂ UB0 + Ntm  .
Uncertainty estimation
A fundamental issue in general CR analyses is the quantification of uncertainty surrounding the estimates of the unknown
population size. An estimation of the population size can be correctly computed, but if the associated estimation of variance is poor,
then coverage by the 95% confidence interval may falsely indicate poor estimation by the point estimator, i.e. the point estimator
may result in a poor coverage rate. Focusing on the proposed upper-bound estimator, we attempt here to investigate bootstrap
methods as a robust and general approach to estimate variances and confidence intervals. Various bootstrap methods have been
considered to estimate uncertainty in CR analyses with respect to other estimators (Anan, Böhning, and Maruotti 2017; Buckland
and Garthwaite 1991; Norris and Pollock 1996; Zwane and van der Heijden 2003). In the following, we consider two different
bootstrap approaches to approximate the uncertainty surrounding the point estimate: the imputed and the reduced bootstrap
approaches.
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Under the imputedbootstrap approach,wedraw 1,000bootstrapped samples of sizeNUB generated according to amultinomial
model whose probabilities are given by










where NUB(t)  f̂ UB0 (t) + f1(t) + f2(t) + f3(t) .
Differently, under the reduced bootstrap approach, each of the bootstrapped samples contains n∗obs(t)  f1(t) + f2(t) + f3(t)
observations generated according to amultinomial model whose probabilities are given by{ f1(t)n∗obs(t), f2(t)n∗obs(t), f3(t)n∗obs(t)}. For each of the two
approaches, the upper boundNUB is computed for eachbootstrapped sample, by summingupover the timeperiod.Of course, for the
imputed bootstrap the fraction of undetected cases is dropped and considered unknown when computing the population size. We
report the 2.5 and 97.5% values of NUB distribution. This allows us to overcome issues often encountered in the construction of the
symmetric confidence intervals (Chao 1987): the sampling distribution could be skewed, the coverage probabilities may be
unsatisfactory, etc.
Data analysis
The example provided here relies on European data. The time series of cumulative cases and deaths up to 17/
04/2020 are considered and are taken from https://github.com/open-covid-19/data. A graphical representa-
tion of the data at hand is shown in Figure 1. The method is implemented in the asymptor package (Gruson
2020) of the R software.
Data from the day which we record the first death are analyzed only. We obtain the estimates of an upper
bound for undetected cases for several European countries (see Table 1). The last column in Table 1 shows the
ratio of the total estimated cases to the observed cases. The ratio of the total estimated cases (in the worse
scenario) to the observed cases is interesting in itself. A ratio of 4.5 wouldmean that for every observed patient
Figure 1: Cases and deaths for the analyzed countries.
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there are 3.5 infected persons unseen. The reason for this can be manifold as these unseen cases might be
without symptoms or show very mild signs of infection.
As expected, the undetected cases represent a relevant portion of the total number of cases. This is in line
with a few existing works and discussions on the topic, see e.g. (Day 2020; La Stampa 2020; WHO 2020). The
number of total number of cases are at most approximately 4.5 times the observed cases. Of course, differences
arise at the country level, and heterogeneous estimates ranging from the 3.93 times of Norway to the 7.94 times
of France, see Table 1. A recent study by the LMUMunich lead by Professor Hölscher shows that the amount of
total infections (including those not identified) is four times higher than the officially register number of
infections (http://www.klinikum.uni-muenchen.de/Abteilung-fuer-Infektions-und-Tropenmedizin/de/COVID-19/
KoCo19/Aktuelles/index.html). These differences are due to different heterogeneity structures in the cases and
deaths time series at the country level. These results are telling us that COVID-19 outbreak was more prevalent
than described by the official data, though a significant number of individuals that are infected actually remain
asymptomatic.
Point estimates can be used to synthetically describe the COVID-19 outbreak, but they may be rather
uncertain. In Table 1, we also provide uncertainty measures, based on the bootstrap procedures described in
Section “Uncertainity estimation”. It is also possible to compare the two employed bootstrap approaches. They
perform rather similarly (see also Anan, Böhning, and Maruotti 2017) and the bootstrap intervals are rather
narrow, with France only showing a rather wide interval to indicate that its point estimate should taken with
caution.
These results can be easily compared with those obtained in the works cited in the introduction. Results
fromLi et al. (2020), Pollan et al. (2020) and Yu et al. (2020) are in linewith ours, and approximately 60–80%of
the total cases are estimated as undetected. Mukhopadhyay and Chakraborty (2020) analyze data from India
(not included in our sample), and estimates that the total number of infections is eight times the observed ones;
this is a bit higher ratio than the one estimated for western countries. At last, substantial differences for some
countries arise with the work of Phipps et al. (2020), though similar results are obtained for Austria and
Norway; but the assumptions underlying their approach are different from ours.
Conclusions
Different capture–recapture approaches have beenused to estimate the size of a partially observed population;
many parametric or semi-parametric models have been developed to estimate the population size from
aggregated counts leading to an approximation of the missed population and/or to the estimate of the
threshold under which the number of missed people cannot fall (i.e. a lower bound). While several proposals


















Italy , , (,–,) (,–,) . (.–.) (.–.)
Austria , , (,–,) (,–,) . (.–.) (.–.)
Germany , , (,–,) (,–,) . (.–.) (.–.)
Spain , , (,–,) (,–,) . (.–.) (.–.)
France , , (,–,) (,–,) . (.–.) (.–.)
UK , , (,–,) (,–,) . (.–.) (.–.)
Greece , , (,–,) (,–,) . (.–.) (.–.)
Belgium , , (,–,) (,–,) . (.–.) (.–.)
Norway , , (,–,) (,–,) . (.–.) .–.
Sweden , , (,–,) (,–,) . (.–.) (.–.)
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for the latter exist, the estimation of an upper bound in capture recapture methods has been often overlooked,
with the exception of the recent work of Alfó et al. (2020). We propose an extension of the upper bound
estimator under cumulative data distributions, in an open population, such that a day-wise estimator varying
over time. The approach results in a time-aggregated approximation for f0 and thus for N. The proposed upper
bound estimator has been applied to registered cases in some European countries; confidence intervals for N
have been provided by employing bootstrap approaches. We consider, for each country, data up to the 17 of
April, by assuming, given also the daywise nature of the estimator, that the recoveries are negligible. Themain
result is that, during the first wave, we are under-diagnosing the amount of infection in the population; and
because of this, a large amount of the population moves normally, thus transmitting the disease. The hidden
number ismore important for transmission than the observed infections as thesewill be going in self-isolation.
The larger the hidden amount, the more difficult is the control of the disease. Accordingly, we need more
testing to have a better understanding of the amount of infection in the population.We should also test persons
without symptoms, but it is no feasible to test everyone. Indeed, the economic and human resources required
to continuously monitoring, at regular short intervals, the entire population may be not realistic. We have
already seen difficulties in tracing and testing direct contacts of infected people inmany European countries. A
possible alternative is to apply sampling techniques, based on e.g. pooling or adaptive strategies. Comparison
of molecular testing strategies for COVID-19 control are given, for example, in Grassly et al. (2020). To sum-
marize existing results from the literature, the most effective approach to reduce onwards transmission is self-
isolation of symptomatic individuals. Screening of high-risk groups (e.g. health-care workers) irrespective of
symptoms by use of PCR testing may also play a fundamental role. The effectiveness of test and trace depends
strongly on coverage and the timeliness of contact tracing. Antibody tests performance has been highly
variable and may produce considerably uncertain results to judge for the effectiveness of this strategy.
However when dealingwith cases and deaths at amore recent date, given the increased percentage of immune
people, recoveries should be taken into account in the computation. Another issuewhich should be considered
is the one concerning the role of the deaths: even when the number of confirmed cases for two different
countries are close to each other the upper bounds can be different according to the deaths size with respect to
the cases (i.e. France and Spain). The length of the observation window plays an important role in this context
and according to the distribution of COVID-19 cases observed more than once, the distribution can be less or
more stable. It appears necessary to analyze this issue more deeply and we propose to do this in a future work.
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